VP of M&A Andrew Goldfein leads the new partnership team, ensuring a smooth and transparent process for prospective partners. He focuses on fully understanding what makes each practice and team special, aiming to support and build on their success rather than fitting them into a mold. Andrew is dedicated to preserving the culture and soul of each practice while facilitating improvements. He and his team work closely with prospective partners to educate them on the opportunities with Alpha, aligning expectations to avoid any big surprises once they join. Andrew ensures that joining Alpha is an incredible experience and the right decision for each partner.

Additionally, he collaborates with the rest of the Alpha team, investors, and lenders to ensure everyone is on the same page, setting up partnerships for long-term success. Andrew also values learning from all partners to create a brain trust of the brightest business minds and most advanced clinicians in aesthetics, fostering a collaborative environment where knowledge is shared to make everyone better.

Andrew loves hearing stories from partners about their early days and how they built their teams and businesses to where they are today. He finds great satisfaction in learning about their journeys, understanding their unique challenges and successes, and using this knowledge to support and enhance their practices as they join Alpha.

Andrew brings valuable experience from his previous roles at Houlihan Lokey, Surgical Care Affiliates, and Affordable Care. His background in investment banking, surgery center management, and working with one of the largest DSOs in the nation equips him with the expertise and insights necessary to effectively lead M&A activities and support partners at Alpha.

Andrew Goldfein has several notable achievements throughout his career. He has worked on hundreds of transactions with healthcare companies and providers, showcasing his extensive expertise in the field. Additionally, he played a significant role in a private equity liquidity event during his time at Affordable Care, which was a $2.7 billion transaction at an industry-leading multiple. These accomplishments highlight his deep knowledge and successful track record in M&A activities.